Market Snapshot

BSE Sensex: 83712.51 0.32%
BSE 500: 36999.02 0.14%
BSE 200: 11581.41 0.18%
BSE 100: 26750.87 0.23%
BSE MidCap: 46748.41 0.01%
BSE SmallCap: 54558.85 -0.17%
BSE BANKEX: 64036.82 0.72%
BSE IT: 38176.09 0.28%
Nifty 50: 25522.5 0.24%
Nifty 500: 23572.55 0.09%
Nifty 200: 14233.25 0.14%
Nifty 100: 26126.05 0.20%
Nifty Midcap 100: 59415.45 -0.17%
Nifty Small 100: 18895.2 -0.29%
Nifty IT: 38983.25 0.30%
Nifty PSU Bank: 7123.2 -0.25%

News:

Belrise Industries ends sharpl...
Edelweiss Financial to underta...
Macrotech Developers achieves ...
SPML Infra secures Rs 205-cror...
Ventive Hospitality jumps afte...

Hikal Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

08 Jul 2025 | 03:59 PM

343.90

2.20 (0.64%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-3.6%

Return (1Y)

Underperformed BSE Healthcare by 20.54%
More Volatile

2.73%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.68%
Not so consistent

5/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

464

309

News & Announcements

Hikal clears ANVISA GMP audit at Bengaluru API unit
22 days ago

Hikal clears ANVISA GMP audit at Bengaluru API unit

17 - Jun - 2025 12:00 | 22 days ago

The audit, which covered multiple active pharmaceutical ingredients (APIs), was conducted from 14 April to 18 April 2025.
The successful completion of the inspection reinforces Hikal?s compliance with international quality standards and strengthens its position in regulated markets like Brazil.
Hikal is engaged in the business of pharmaceuticals, crop protection, and specialty chemicals.
The company?s consolidated net profit rallied 48.08% to Rs 50.20 crore on 7.44% rise in revenue from operations to Rs 552.40 crore in Q4 FY25 over Q4 FY24.
Shares of Hikal rose 0.29% to Rs 377.10 on the BSE.
Powered by Capital Market - Live News

Hikal consolidated net profit rises 48.08% in the March 2025 quarter

56 days ago

Hikal standalone net profit rises 48.82% in the March 2025 quarter

56 days ago

Board of Hikal approves change in directorate
56 days ago

Board of Hikal approves change in directorate

14 - May - 2025 12:00 | 56 days ago

The Board of Hikal at its meeting held on 14 May 2025 has approved redesignation of Sameer Hiremath (DIN: 00062129), Managing Director as Vice Chairman & Managing Director.
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Hikal Ltd has decreased by -6.01% since past 3 Months
FII shareholding in Hikal Ltd has decreased by -13.11% since past 1 Year
MF shareholding in Hikal Ltd has decreased by -3.17% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60